首页 > 最新文献

Brain & Development最新文献

英文 中文
Polysomnographic and clinical features of childhood non-REM parasomnias: A sleep center experience 儿童非快速眼动睡眠异常的多导睡眠图和临床特征:睡眠中心经验。
IF 1.3 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-16 DOI: 10.1016/j.braindev.2025.104465
Aslı Çıplaklıgil , Duygu Kurt Gök , Hüseyin Per , Sevda İsmailoğulları

Introduction

Non-REM parasomnias are common in childhood, yet studies investigating their clinical and polysomnographic features remain limited. This study aimed to assess the clinical and sleep characteristics of children diagnosed with non-rapid eye movement (non-REM) parasomnias and to describe the semiological features of episodes confirmed by video-polysomnography (vPSG).

Method

We retrospectively evaluated 88 children (2–18 years) referred with abnormal nocturnal motor behaviors who underwent overnight vPSG between 2016 and 2023. Demographic and clinical data, comorbidities, and electroencephalography (EEG) findings were recorded. In cases with observed parasomnia episodes on vPSG, motor patterns, EEG, electrocardiography (ECG) characteristics, and Frontal Lobe Epilepsy-Parasomnia (FLEP) scale scores were analyzed. Parasomnia episodes were classified based on motor complexity: simple, rising, and complex arousal movements.

Results

Sixty-nine (78.4 %) patients referred for abnormal nocturnal behaviors were diagnosed with non-REM parasomnias by International Classification of Sleep Disorders-3 (ICSD-3), 20 (29 %) had confirmed episodes during vPSG (15 confusional arousal, 4 sleep terror, 1 somnambulism). Most episodes (91.1 %) occurred during N3 sleep. Simple arousal was the most common pattern (88.2 %). Episodes with complex motor features were longer and associated with autonomic signs such as tachycardia. Patients with comorbid epilepsy had a lower vPSG-confirmation rate (5.2 %) and higher FLEP scores. Electroencephalogram patterns included hypersynchronous delta and mixed-frequency theta-alpha activity.

Conclusion

This study characterized the semiological features of non-REM parasomnia episodes in pediatric patients. Although vPSG findings contributed to the objective description of motor patterns, the current data are not sufficient to conclude that vPSG is definitively useful for differential diagnosis. However, vPSG may aid in clarifying symptom profiles and excluding other comorbid conditions.
非快速眼动睡眠异常在儿童时期很常见,但对其临床和多导睡眠图特征的研究仍然有限。本研究旨在评估诊断为非快速眼动(non-REM)睡眠异常的儿童的临床和睡眠特征,并描述视频多导睡眠图(vPSG)证实的发作的符号学特征。方法:我们回顾性评估了2016年至2023年间88名夜间运动行为异常的儿童(2-18岁)。记录了人口统计学和临床资料、合并症和脑电图(EEG)结果。在vPSG上观察到睡眠异常发作的病例中,分析运动模式、脑电图、心电图(ECG)特征和额叶癫痫-睡眠异常(FLEP)量表评分。睡眠异常发作是根据运动复杂性来分类的:简单的、上升的和复杂的觉醒运动。结果:69例(78.4%)夜间异常行为患者被《国际睡眠障碍分类-3》(ICSD-3)诊断为非快速眼动睡眠异常,20例(29%)在vPSG期间确诊发作(15例混淆觉醒,4例睡眠恐怖,1例梦游)。大多数发作(91.1%)发生在N3睡眠。单纯性兴奋是最常见的模式(88.2%)。具有复杂运动特征的发作时间较长,并伴有自主神经体征,如心动过速。合并癫痫的患者vpsg确认率较低(5.2%),而FLEP评分较高。脑电图模式包括超同步δ和混合频率θ - α活动。结论:本研究描述了儿童非快速眼动睡眠异常发作的符号学特征。尽管vPSG的发现有助于对运动模式的客观描述,但目前的数据还不足以得出vPSG对鉴别诊断确实有用的结论。然而,vPSG可能有助于澄清症状概况和排除其他合并症。
{"title":"Polysomnographic and clinical features of childhood non-REM parasomnias: A sleep center experience","authors":"Aslı Çıplaklıgil ,&nbsp;Duygu Kurt Gök ,&nbsp;Hüseyin Per ,&nbsp;Sevda İsmailoğulları","doi":"10.1016/j.braindev.2025.104465","DOIUrl":"10.1016/j.braindev.2025.104465","url":null,"abstract":"<div><h3>Introduction</h3><div>Non-REM parasomnias are common in childhood, yet studies investigating their clinical and polysomnographic features remain limited. This study aimed to assess the clinical and sleep characteristics of children diagnosed with non-rapid eye movement (non-REM) parasomnias and to describe the semiological features of episodes confirmed by video-polysomnography (vPSG).</div></div><div><h3>Method</h3><div>We retrospectively evaluated 88 children (2–18 years) referred with abnormal nocturnal motor behaviors who underwent overnight vPSG between 2016 and 2023. Demographic and clinical data, comorbidities, and electroencephalography (EEG) findings were recorded. In cases with observed parasomnia episodes on vPSG, motor patterns, EEG, electrocardiography (ECG) characteristics, and Frontal Lobe Epilepsy-Parasomnia (FLEP) scale scores were analyzed. Parasomnia episodes were classified based on motor complexity: simple, rising, and complex arousal movements.</div></div><div><h3>Results</h3><div>Sixty-nine (78.4 %) patients referred for abnormal nocturnal behaviors were diagnosed with non-REM parasomnias by International Classification of Sleep Disorders-3 (ICSD-3), 20 (29 %) had confirmed episodes during vPSG (15 confusional arousal, 4 sleep terror, 1 somnambulism). Most episodes (91.1 %) occurred during N3 sleep. Simple arousal was the most common pattern (88.2 %). Episodes with complex motor features were longer and associated with autonomic signs such as tachycardia. Patients with comorbid epilepsy had a lower vPSG-confirmation rate (5.2 %) and higher FLEP scores. Electroencephalogram patterns included hypersynchronous delta and mixed-frequency theta-alpha activity.</div></div><div><h3>Conclusion</h3><div>This study characterized the semiological features of non-REM parasomnia episodes in pediatric patients. Although vPSG findings contributed to the objective description of motor patterns, the current data are not sufficient to conclude that vPSG is definitively useful for differential diagnosis. However, vPSG may aid in clarifying symptom profiles and excluding other comorbid conditions.</div></div>","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"47 6","pages":"Article 104465"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145314267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on “Survival motor neuron protein is the optimal biomarker for evaluating the risdiplam treatment” 关于“存活运动神经元蛋白是评价利西泮治疗效果的最佳生物标志物”的评论
IF 1.3 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-11-14 DOI: 10.1016/j.braindev.2025.104486
Gül Yücel
{"title":"Comment on “Survival motor neuron protein is the optimal biomarker for evaluating the risdiplam treatment”","authors":"Gül Yücel","doi":"10.1016/j.braindev.2025.104486","DOIUrl":"10.1016/j.braindev.2025.104486","url":null,"abstract":"","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"47 6","pages":"Article 104486"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145520346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: “When neutral isn't negative: missteps in survey data analysis” 回复:“当中性并非消极:调查数据分析中的失误”
IF 1.3 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-30 DOI: 10.1016/j.braindev.2025.104481
Tetsuya Okazaki , Chisako Aoki , Saki Shinzato , Kaori Adachi , Eiji Nanba
{"title":"Reply to: “When neutral isn't negative: missteps in survey data analysis”","authors":"Tetsuya Okazaki ,&nbsp;Chisako Aoki ,&nbsp;Saki Shinzato ,&nbsp;Kaori Adachi ,&nbsp;Eiji Nanba","doi":"10.1016/j.braindev.2025.104481","DOIUrl":"10.1016/j.braindev.2025.104481","url":null,"abstract":"","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"47 6","pages":"Article 104481"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145417924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of therapeutic instrumental music performance on upper limb motor function of children with cerebral palsy: A systematic review 治疗性器乐演奏对脑瘫儿童上肢运动功能的影响:系统回顾。
IF 1.3 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-13 DOI: 10.1016/j.braindev.2025.104468
Zhuolin Wu , Meijiao Wu
Therapeutic instrumental music performance (TIMP) can be used to improve limb motor function in children with cerebral palsy (CwCP). The purpose of this systematic review is to further analyze the potential therapeutic effects of TIMP on upper limb motor function in CwCP. We used the terms "“music,"” "“therapeutic instrumental music performance,"” "“musical instruments,"” "“cerebral palsy,"” "“children,"” "“upper limb,"” and "“upper extremity"” as our search keywords, and conducted a search of articles published in English and Chinese databases: PubMed, Cochrane, Web of Science, Wiley Online Library, CINAHL, and CNKI, Wanfang Data as of March 2025. Initially, 409 articles were retrieved. After screening titles and abstracts and assessing eligibility, eight studies were included in this review. All studies assessed hand fine motor function, and five also evaluated upper limb gross motor function. Three studies used only keyboard instruments, two exclusively percussion instruments, and three combined keyboard, percussion, and plucked instruments. The results demonstrated that TIMP effectively improves upper limb motor function in CwCP.
治疗性器乐演奏(TIMP)可用于改善脑瘫(CwCP)患儿肢体运动功能。本系统综述的目的是进一步分析TIMP对CwCP上肢运动功能的潜在治疗作用。我们以“音乐,“” “”治疗性器乐演奏,“” “”乐器,“” “”脑瘫,“” “”儿童,“” “”上肢”和“上肢”作为搜索关键词,检索了截至2025年3月在PubMed, Cochrane, Web of Science, Wiley Online Library, CINAHL, CNKI,万方数据等中英文数据库中发表的文章。最初,检索了409篇文章。在筛选标题和摘要并评估合格性后,本综述纳入了8项研究。所有研究都评估了手部精细运动功能,其中5项研究还评估了上肢大运动功能。三项研究只使用键盘乐器,两项研究只使用打击乐器,三项研究将键盘、打击乐器和弹拨乐器结合使用。结果表明,TIMP能有效改善CwCP患者上肢运动功能。
{"title":"Effects of therapeutic instrumental music performance on upper limb motor function of children with cerebral palsy: A systematic review","authors":"Zhuolin Wu ,&nbsp;Meijiao Wu","doi":"10.1016/j.braindev.2025.104468","DOIUrl":"10.1016/j.braindev.2025.104468","url":null,"abstract":"<div><div>Therapeutic instrumental music performance (TIMP) can be used to improve limb motor function in children with cerebral palsy (CwCP). The purpose of this systematic review is to further analyze the potential therapeutic effects of TIMP on upper limb motor function in CwCP. We used the terms \"“music,\"” \"“therapeutic instrumental music performance,\"” \"“musical instruments,\"” \"“cerebral palsy,\"” \"“children,\"” \"“upper limb,\"” and \"“upper extremity\"” as our search keywords, and conducted a search of articles published in English and Chinese databases: PubMed, Cochrane, Web of Science, Wiley Online Library, CINAHL, and CNKI, Wanfang Data as of March 2025. Initially, 409 articles were retrieved. After screening titles and abstracts and assessing eligibility, eight studies were included in this review. All studies assessed hand fine motor function, and five also evaluated upper limb gross motor function. Three studies used only keyboard instruments, two exclusively percussion instruments, and three combined keyboard, percussion, and plucked instruments. The results demonstrated that TIMP effectively improves upper limb motor function in CwCP.</div></div>","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"47 6","pages":"Article 104468"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145294472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to response to the letter to the editor “Decoding the pathophysiological role of Fukutin in Fukuyama congenital muscular dystrophy” 回复给编辑的信“解码Fukutin在福山先天性肌营养不良症中的病理生理作用”。
IF 1.3 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-16 DOI: 10.1016/j.braindev.2025.104473
Christian Messina
{"title":"Response to response to the letter to the editor “Decoding the pathophysiological role of Fukutin in Fukuyama congenital muscular dystrophy”","authors":"Christian Messina","doi":"10.1016/j.braindev.2025.104473","DOIUrl":"10.1016/j.braindev.2025.104473","url":null,"abstract":"","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"47 6","pages":"Article 104473"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145314302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refractory myoclonic epilepsy and progressive movement disorder arising from recurrent DHDDS variants in Japanese patients: a case series 日本患者复发性DHDDS变异引起的难治性肌阵挛性癫痫和进行性运动障碍:一个病例系列
IF 1.3 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-18 DOI: 10.1016/j.braindev.2025.104478
Yu Kobayashi , Satoru Sakuma , Emiko Morimoto , Hitomi Fujii , Kei Yamada , Moemi Hojo , Masaki Miura , Jun Tohyama , Fuyuki Miya , Mitsuhiro Kato , Hirotomo Saitsu , Naomichi Matsumoto

Objective

Heterozygous DHDDS variants have been associated with intellectual disability and seizures, with or without movement disorders. We aimed to expand the known phenotypic spectrum of DHDDS-related disorders by elucidating the clinical characteristics of Japanese patients with recurrent DHDDS variants.

Methods

Patients with pathogenic DHDDS variants were recruited from individuals diagnosed with developmental and epileptic encephalopathy or progressive myoclonus epilepsies who were treated at the Department of Child Neurology, National Hospital Organization Nishiniigata Chuo Hospital, or the Department of Pediatrics, Osaka Metropolitan University Graduate School of Medicine. DHDDS pathogenic variants were identified using exome sequencing. Medical records and neurophysiological data were retrospectively reviewed.

Results

Three de novo recurrent pathogenic DHDDS variants were identified in four patients: c.632G>A, p.(Arg211Gln) in two; c.614G>A, p.(Arg205Gln) in one; and c.110G>A, p.(Arg37His) in one. Three patients with p.(Arg211Gln) or p.(Arg37His) presented with severe intellectual disability and intractable generalized epilepsy, characterized by myoclonic, myoclonic–atonic, and atonic seizures. Eyelid myoclonia was the initial manifestation in infancy. One patient with p.(Arg205Gln) had a relatively mild course, with focal epilepsy and less severe intellectual disability. Myoclonus and tremor were present from infancy in two patients with p.(Arg211Gln) or p.(Arg37His), and from childhood in the patient with p.(Arg205Gln). One patient with p.(Arg211Gln) exhibited polymicrogyria in the right frontal lobe. Among the three patients with generalized epilepsy, fenfluramine effectively reduced myoclonic seizures in one, while total corpus callosotomy markedly reduced myoclonic–atonic or atonic seizures with falls in another.

Conclusion

DHDDS-related disorders should be considered in patients with intellectual disability, epilepsy with early-onset eyelid myoclonia and myoclonic or myoclonic–atonic seizures, and movement disorders, including myoclonus and tremor, with slow progression. We identified polymicrogyria as a novel finding in DHDDS patients. For drug-resistant epilepsy in these patients, corpus callosotomy and fenfluramine may represent promising treatment options, with this report providing specific insights into their efficacy.
目的杂合DHDDS变异与智力残疾和癫痫发作相关,伴或不伴运动障碍。我们的目的是通过阐明日本复发性DHDDS变异患者的临床特征,扩大已知的DHDDS相关疾病的表型谱。方法从在国立医院组织西西中央医院儿童神经内科或大阪城市大学医学院儿科治疗的被诊断为发育性和癫痫性脑病或进行性肌克隆性癫痫的患者中招募致病性DHDDS变异患者。利用外显子组测序鉴定DHDDS致病变异。回顾性分析医疗记录和神经生理学资料。结果4例患者中发现3种新发复发致病性DHDDS变异体:2例c.632G>;A, p.(Arg211Gln);c.614G>;A, p.(Arg205Gln) in one;和c. 110g;A, p.(Arg37His)合而为一。3例p.(Arg211Gln)或p.(Arg37His)患者表现为严重智力障碍和顽固性全身性癫痫,其特征为肌阵挛性、肌阵挛性-张力性和张力性发作。眼睑肌阵挛最初表现在婴儿期。1例p.(Arg205Gln)患者病程相对较轻,伴有局灶性癫痫和较轻的智力残疾。2例p (Arg211Gln)或p (Arg37His)患者从婴儿期开始出现肌阵挛和震颤,p (Arg205Gln)患者从儿童期开始出现肌阵挛和震颤。1例p.(Arg211Gln)患者右侧额叶出现多小回症。在3例全身性癫痫患者中,芬氟拉明有效地减少了1例肌阵挛性发作,而全胼胝体切开术显著减少了1例肌阵挛性失张力或失张力性发作伴跌倒。结论智力残疾、癫痫伴早发性眼睑肌阵挛、肌阵挛或肌阵挛性无张力发作、运动障碍(包括肌阵挛和震颤)进展缓慢的患者应考虑dhdds相关疾病。我们确定多小回症是DHDDS患者的新发现。对于这些患者的耐药癫痫,胼胝体切开术和芬氟拉明可能是有希望的治疗选择,本报告提供了对其疗效的具体见解。
{"title":"Refractory myoclonic epilepsy and progressive movement disorder arising from recurrent DHDDS variants in Japanese patients: a case series","authors":"Yu Kobayashi ,&nbsp;Satoru Sakuma ,&nbsp;Emiko Morimoto ,&nbsp;Hitomi Fujii ,&nbsp;Kei Yamada ,&nbsp;Moemi Hojo ,&nbsp;Masaki Miura ,&nbsp;Jun Tohyama ,&nbsp;Fuyuki Miya ,&nbsp;Mitsuhiro Kato ,&nbsp;Hirotomo Saitsu ,&nbsp;Naomichi Matsumoto","doi":"10.1016/j.braindev.2025.104478","DOIUrl":"10.1016/j.braindev.2025.104478","url":null,"abstract":"<div><h3>Objective</h3><div>Heterozygous <em>DHDDS</em> variants have been associated with intellectual disability and seizures, with or without movement disorders. We aimed to expand the known phenotypic spectrum of <em>DHDDS</em>-related disorders by elucidating the clinical characteristics of Japanese patients with recurrent <em>DHDDS</em> variants.</div></div><div><h3>Methods</h3><div>Patients with pathogenic <em>DHDDS</em> variants were recruited from individuals diagnosed with developmental and epileptic encephalopathy or progressive myoclonus epilepsies who were treated at the Department of Child Neurology, National Hospital Organization Nishiniigata Chuo Hospital, or the Department of Pediatrics, Osaka Metropolitan University Graduate School of Medicine. <em>DHDDS</em> pathogenic variants were identified using exome sequencing. Medical records and neurophysiological data were retrospectively reviewed.</div></div><div><h3>Results</h3><div>Three <em>de novo</em> recurrent pathogenic <em>DHDDS</em> variants were identified in four patients: c.632G&gt;A, p.(Arg211Gln) in two; c.614G&gt;A, p.(Arg205Gln) in one; and c.110G&gt;A, p.(Arg37His) in one. Three patients with p.(Arg211Gln) or p.(Arg37His) presented with severe intellectual disability and intractable generalized epilepsy, characterized by myoclonic, myoclonic–atonic, and atonic seizures. Eyelid myoclonia was the initial manifestation in infancy. One patient with p.(Arg205Gln) had a relatively mild course, with focal epilepsy and less severe intellectual disability. Myoclonus and tremor were present from infancy in two patients with p.(Arg211Gln) or p.(Arg37His), and from childhood in the patient with p.(Arg205Gln). One patient with p.(Arg211Gln) exhibited polymicrogyria in the right frontal lobe. Among the three patients with generalized epilepsy, fenfluramine effectively reduced myoclonic seizures in one, while total corpus callosotomy markedly reduced myoclonic–atonic or atonic seizures with falls in another.</div></div><div><h3>Conclusion</h3><div><em>DHDDS</em>-related disorders should be considered in patients with intellectual disability, epilepsy with early-onset eyelid myoclonia and myoclonic or myoclonic–atonic seizures, and movement disorders, including myoclonus and tremor, with slow progression. We identified polymicrogyria as a novel finding in <em>DHDDS</em> patients. For drug-resistant epilepsy in these patients, corpus callosotomy and fenfluramine may represent promising treatment options, with this report providing specific insights into their efficacy.</div></div>","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"47 6","pages":"Article 104478"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145326434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical profiles of tuberous sclerosis complex: A regionally based survey 结节性硬化症的临床概况:一项基于区域的调查
IF 1.3 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-25 DOI: 10.1016/j.braindev.2025.104479
Misae Yamada , Jun Natsume , Yuki Maki , Soichiro Ishimaru , Shingo Numoto , Satoru Kobayashi , Ayako Hattori , Yoshihisa Matsukawa , Keiko Wakahara , Naoko Ishihara , Hitomi Sasaki , Yuji Ito , Hiroyuki Yamamoto , Tomohiko Nakata , Hiroyuki Kidokoro , Tetsushi Yoshikawa , Shinji Saitoh , Akihisa Okumura , Yoshiyuki Takahashi

Background

This study aimed to clarify the clinical profiles of patients with tuberous sclerosis complex (TSC) in the general population by a regionally based survey of medical facilities in a region with 7.5 million residents, and investigate differences in clinical profiles according to medical facility size and type.

Methods

A survey was sent to 146 hospitals and clinics regarding clinical profiles of patients with TSC who lived in Aichi Prefecture, Japan, between 2013 and 2018. Medical facilities were classified as large hospitals (≥750 beds or a children's hospital), small hospitals (<750 beds), institutions for handicapped children, and private clinics.

Results

Information was obtained of 232 patients (median age, 25 years; range, 1–81 years). Estimated prevalence of TSC was 3.1 per 100,000. Cortical tubers were present in 88 %, epilepsy in 81 %, autism spectrum disorder in 44 %, and subependymal giant cell astrocytoma in 17 %. Hypomelanotic macules, facial angiofibroma, renal angiomyolipoma, and cardiac rhabdomyoma were present in >50 % of patients. Rates of epilepsy with frequent seizures and autism spectrum disorder were both higher in patients in institutions for handicapped children. In more than half of patients in institutions for handicapped children information on cranial MRI findings was not obtained.

Conclusions

Our regionally based study confirmed the clinical profiles previously reported in specialized hospitals for TSC and found that clinical characteristics differed among the types and sizes of medical facilities. Multicenter information sharing and collaboration between general hospitals and institutions for handicapped children are important for the comprehensive care of patients with TSC.
本研究旨在通过对一个拥有750万居民的地区的医疗机构进行区域性调查,阐明普通人群中结节性硬化症(TSC)患者的临床概况,并根据医疗机构的规模和类型调查临床概况的差异。方法对2013 - 2018年居住在日本爱知县的146家医院和诊所进行TSC患者临床资料调查。医疗设施分为大型医院(≥750张床位或儿童医院)、小型医院(<;750张床位)、残疾儿童机构和私人诊所。结果获得232例患者的信息(中位年龄25岁,范围1 ~ 81岁)。估计TSC患病率为每10万人3.1例。皮质结节占88%,癫痫占81%,自闭症谱系障碍占44%,室管膜下巨细胞星形细胞瘤占17%。50%的患者存在低黑色素斑疹、面部血管纤维瘤、肾脏血管平滑肌脂肪瘤和心脏横纹肌瘤。在残疾儿童收容机构的患者中,频繁发作的癫痫和自闭症谱系障碍的发病率都较高。在残疾儿童机构中,超过一半的患者没有获得有关颅MRI发现的信息。结论基于区域的研究证实了以往在专科医院报道的TSC的临床特征,并发现不同医疗设施类型和规模的临床特征存在差异。综合医院和残疾儿童机构之间的多中心信息共享和协作对于TSC患者的综合护理非常重要。
{"title":"Clinical profiles of tuberous sclerosis complex: A regionally based survey","authors":"Misae Yamada ,&nbsp;Jun Natsume ,&nbsp;Yuki Maki ,&nbsp;Soichiro Ishimaru ,&nbsp;Shingo Numoto ,&nbsp;Satoru Kobayashi ,&nbsp;Ayako Hattori ,&nbsp;Yoshihisa Matsukawa ,&nbsp;Keiko Wakahara ,&nbsp;Naoko Ishihara ,&nbsp;Hitomi Sasaki ,&nbsp;Yuji Ito ,&nbsp;Hiroyuki Yamamoto ,&nbsp;Tomohiko Nakata ,&nbsp;Hiroyuki Kidokoro ,&nbsp;Tetsushi Yoshikawa ,&nbsp;Shinji Saitoh ,&nbsp;Akihisa Okumura ,&nbsp;Yoshiyuki Takahashi","doi":"10.1016/j.braindev.2025.104479","DOIUrl":"10.1016/j.braindev.2025.104479","url":null,"abstract":"<div><h3>Background</h3><div>This study aimed to clarify the clinical profiles of patients with tuberous sclerosis complex (TSC) in the general population by a regionally based survey of medical facilities in a region with 7.5 million residents, and investigate differences in clinical profiles according to medical facility size and type.</div></div><div><h3>Methods</h3><div>A survey was sent to 146 hospitals and clinics regarding clinical profiles of patients with TSC who lived in Aichi Prefecture, Japan, between 2013 and 2018. Medical facilities were classified as large hospitals (≥750 beds or a children's hospital), small hospitals (&lt;750 beds), institutions for handicapped children, and private clinics.</div></div><div><h3>Results</h3><div>Information was obtained of 232 patients (median age, 25 years; range, 1–81 years). Estimated prevalence of TSC was 3.1 per 100,000. Cortical tubers were present in 88 %, epilepsy in 81 %, autism spectrum disorder in 44 %, and subependymal giant cell astrocytoma in 17 %. Hypomelanotic macules, facial angiofibroma, renal angiomyolipoma, and cardiac rhabdomyoma were present in &gt;50 % of patients. Rates of epilepsy with frequent seizures and autism spectrum disorder were both higher in patients in institutions for handicapped children. In more than half of patients in institutions for handicapped children information on cranial MRI findings was not obtained.</div></div><div><h3>Conclusions</h3><div>Our regionally based study confirmed the clinical profiles previously reported in specialized hospitals for TSC and found that clinical characteristics differed among the types and sizes of medical facilities. Multicenter information sharing and collaboration between general hospitals and institutions for handicapped children are important for the comprehensive care of patients with TSC.</div></div>","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"47 6","pages":"Article 104479"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145364704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of robotic assisted gait training on physical activity, motor function, and quality of life in children with spastic cerebral palsy: Exploratory pilot study 机器人辅助步态训练对痉挛型脑瘫儿童身体活动、运动功能和生活质量的影响:探索性试点研究
IF 1.3 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-11-08 DOI: 10.1016/j.braindev.2025.104482
Yeon-Gyu Jeong , Won-Cheol Kim , Yeon-Jae Jeong , Ha-Neul Jang , Joo-Young Lee , Jae-Soon Chung , Kyu-Hoon Lee

Background

Children with spastic cerebral palsy (CP) experience motor impairments and reduced physical activity, negatively impacting health and quality of life. Objective: The study aimed to assess the effects of wearable exoskeleton robot-assisted gait training on physical activity, motor function, and quality of life in children with CP. Methods: Ten children with spastic CP (mean age 9.20 ± 2.57 years; gross motor function classification system levels I–IV) received twelve 30-min sessions of robot-assisted gait training over six weeks at a university hospital rehabilitation center. Physical activity was measured using a tri-axial accelerometer to assess energy expenditure, metabolic equivalents (METs), intensity levels, vector magnitude counts per minute (VM CPM), and step counts. Motor function was evaluated using the Gross Motor Function Measure (GMFM), Timed Up and Go Test (TUG), and 6-Minute Walk Test (6MWT). Quality of life was assessed with the Cerebral Palsy Quality of Life questionnaire (CP-QOL). Repeated measures MANOVA and Cohen's d were used for statistical analysis. Results: Significant improvements were observed in METs (p = 0.02, d = 0.38), light (p = 0.03, d = 0.51) and moderate physical activity time (p = 0.01, d = 0.42), and VM CPM (p = 0.02, d = 0.55), along with reduced sedentary time (p = 0.02, d = −0.49). Functional outcomes improved in GMFM (p<0.01, d = 0.22), TUG (p = 0.03, d = −0.33), and 6MWT (p = 0.02, d = 0.52). No significant changes were found in CP-QOL scores. Conclusion: Wearable robot-assisted gait training appears to enhance physical activity and mobility in children with spastic CP and may be considered a promising therapeutic intervention.
背景痉挛性脑瘫(CP)患儿会出现运动障碍和身体活动减少,对健康和生活质量产生负面影响。目的:本研究旨在评估可穿戴外骨骼机器人辅助步态训练对CP患儿身体活动、运动功能和生活质量的影响。方法:10例痉挛性CP患儿(平均年龄9.20±2.57岁,大运动功能分类系统等级I-IV级)在某大学医院康复中心接受了12次30分钟的机器人辅助步态训练,为期6周。使用三轴加速度计测量身体活动,以评估能量消耗、代谢当量(METs)、强度水平、每分钟矢量量级计数(VM CPM)和步数。运动功能通过大运动功能测量(GMFM)、计时起床和行走测试(TUG)和6分钟步行测试(6MWT)进行评估。采用脑瘫生活质量问卷(CP-QOL)评估患者的生活质量。采用重复测量方差分析(MANOVA)和Cohen’s d进行统计分析。结果:在METs (p = 0.02, d = 0.38)、轻度(p = 0.03, d = 0.51)和中度体力活动时间(p = 0.01, d = 0.42)和VM CPM (p = 0.02, d = 0.55)以及减少久坐时间(p = 0.02, d = - 0.49)方面观察到显著改善。功能结果改善GMFM(术中;0.01 d = 0.22),拖船(p = 0.03, d =−0.33),和6 mwt (p = 0.02, d = 0.52)。CP-QOL评分无明显变化。结论:可穿戴机器人辅助的步态训练似乎可以增强痉挛性脑瘫儿童的身体活动和活动能力,可能被认为是一种有前途的治疗干预措施。
{"title":"The effect of robotic assisted gait training on physical activity, motor function, and quality of life in children with spastic cerebral palsy: Exploratory pilot study","authors":"Yeon-Gyu Jeong ,&nbsp;Won-Cheol Kim ,&nbsp;Yeon-Jae Jeong ,&nbsp;Ha-Neul Jang ,&nbsp;Joo-Young Lee ,&nbsp;Jae-Soon Chung ,&nbsp;Kyu-Hoon Lee","doi":"10.1016/j.braindev.2025.104482","DOIUrl":"10.1016/j.braindev.2025.104482","url":null,"abstract":"<div><h3>Background</h3><div>Children with spastic cerebral palsy (CP) experience motor impairments and reduced physical activity, negatively impacting health and quality of life. Objective: The study aimed to assess the effects of wearable exoskeleton robot-assisted gait training on physical activity, motor function, and quality of life in children with CP. Methods: Ten children with spastic CP (mean age 9.20 ± 2.57 years; gross motor function classification system levels I–IV) received twelve 30-min sessions of robot-assisted gait training over six weeks at a university hospital rehabilitation center. Physical activity was measured using a tri-axial accelerometer to assess energy expenditure, metabolic equivalents (METs), intensity levels, vector magnitude counts per minute (VM CPM), and step counts. Motor function was evaluated using the Gross Motor Function Measure (GMFM), Timed Up and Go Test (TUG), and 6-Minute Walk Test (6MWT). Quality of life was assessed with the Cerebral Palsy Quality of Life questionnaire (CP-QOL). Repeated measures MANOVA and Cohen's d were used for statistical analysis. Results: Significant improvements were observed in METs (<em>p</em> = 0.02, d = 0.38), light (<em>p</em> = 0.03, d = 0.51) and moderate physical activity time (<em>p</em> = 0.01, d = 0.42), and VM CPM (<em>p</em> = 0.02, d = 0.55), along with reduced sedentary time (p = 0.02, d = −0.49). Functional outcomes improved in GMFM (<em>p</em>&lt;0.01, d = 0.22), TUG (<em>p</em> = 0.03, d = −0.33), and 6MWT (p = 0.02, d = 0.52). No significant changes were found in CP-QOL scores. Conclusion: Wearable robot-assisted gait training appears to enhance physical activity and mobility in children with spastic CP and may be considered a promising therapeutic intervention.</div></div>","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"47 6","pages":"Article 104482"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145467259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic odyssey of opsoclonus-myoclonus syndrome and barriers to early detection 阵挛-肌阵挛综合征的诊断过程及早期发现的障碍
IF 1.3 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-11-14 DOI: 10.1016/j.braindev.2025.104484
Nobuaki Tsuiki , Itaru Hayakawa , Yuichi Abe

Objectives

Opsoclonus-myoclonus syndrome (OMS) is a rare immune-mediated disorder of central nervous systems characterized by chaotic eye movements (opsoclonus), myoclonus, ataxia, and behavioral disturbances. OMS remains diagnostically challenging despite its recognizable clinical features.

Methods

We conducted a single-center cohort study of patients with OMS at a tertiary care children's medical center (2002–2024). Using the diagnostic odyssey plot methodology, we mapped individual diagnostic pathways, compared early (≤28 days) versus delayed (>28 days) diagnosis groups, and analyzed symptoms as well as patterns of diagnostic errors.

Results

Twenty cases were ascertained. Ten patients were diagnosed early (median 16.5 days), while the remaining experienced a delayed diagnosis (equal to or more than 28 days, median 124 days). Provisional diagnoses of acute cerebellar ataxia, acute disseminated encephalomyelitis, and acute cerebellitis were common. Analysis of symptoms revealed that nystagmus appeared at the same time in both the early- and delayed-diagnosed groups, but opsoclonus was recognized later in the delayed diagnosed group (11.5 days versus 96 days, p < 0.01). The presence or absence of neuroblastoma did not contribute to the diagnostic delay.

Conclusions

The unique diagnostic journey of OMS is presented. Reconsidering the diagnosis in cases of prolonged or relapsing ataxia and recognizing opsoclonus early on are vital for the early detection of OMS.
目的眼阵挛-肌阵挛综合征(OMS)是一种罕见的免疫介导的中枢神经系统疾病,以眼动混乱(眼阵挛)、肌阵挛、共济失调和行为障碍为特征。尽管OMS具有可识别的临床特征,但其诊断仍然具有挑战性。方法对某三级儿童医疗中心(2002-2024)的OMS患者进行单中心队列研究。使用诊断奥德赛图方法,我们绘制了个体诊断途径,比较早期(≤28天)和延迟(>;28天)诊断组,并分析了症状和诊断错误的模式。结果共确诊20例。10例患者早期诊断(中位16.5天),其余患者延迟诊断(等于或超过28天,中位124天)。临时诊断为急性小脑性共济失调,急性播散性脑脊髓炎和急性小脑炎是常见的。症状分析显示,早期和延迟诊断组眼球震颤同时出现,但延迟诊断组眼冠的发现较晚(11.5 d对96 d, p < 0.01)。神经母细胞瘤的存在或不存在不会导致诊断延迟。结论总结了OMS独特的诊断历程。对长期或复发性共济失调的病例重新考虑诊断,及早发现眼阵挛对OMS的早期发现至关重要。
{"title":"Diagnostic odyssey of opsoclonus-myoclonus syndrome and barriers to early detection","authors":"Nobuaki Tsuiki ,&nbsp;Itaru Hayakawa ,&nbsp;Yuichi Abe","doi":"10.1016/j.braindev.2025.104484","DOIUrl":"10.1016/j.braindev.2025.104484","url":null,"abstract":"<div><h3>Objectives</h3><div>Opsoclonus-myoclonus syndrome (OMS) is a rare immune-mediated disorder of central nervous systems characterized by chaotic eye movements (opsoclonus), myoclonus, ataxia, and behavioral disturbances. OMS remains diagnostically challenging despite its recognizable clinical features.</div></div><div><h3>Methods</h3><div>We conducted a single-center cohort study of patients with OMS at a tertiary care children's medical center (2002–2024). Using the diagnostic odyssey plot methodology, we mapped individual diagnostic pathways, compared early (≤28 days) versus delayed (&gt;28 days) diagnosis groups, and analyzed symptoms as well as patterns of diagnostic errors.</div></div><div><h3>Results</h3><div>Twenty cases were ascertained. Ten patients were diagnosed early (median 16.5 days), while the remaining experienced a delayed diagnosis (equal to or more than 28 days, median 124 days). Provisional diagnoses of acute cerebellar ataxia, acute disseminated encephalomyelitis, and acute cerebellitis were common. Analysis of symptoms revealed that nystagmus appeared at the same time in both the early- and delayed-diagnosed groups, but opsoclonus was recognized later in the delayed diagnosed group (11.5 days versus 96 days, <em>p</em> &lt; 0.01). The presence or absence of neuroblastoma did not contribute to the diagnostic delay.</div></div><div><h3>Conclusions</h3><div>The unique diagnostic journey of OMS is presented. Reconsidering the diagnosis in cases of prolonged or relapsing ataxia and recognizing opsoclonus early on are vital for the early detection of OMS.</div></div>","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"47 6","pages":"Article 104484"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145520433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurological manifestations and clinical outcomes in pediatric Alexander disease: single-center cohort and identification of novel GFAP variants 小儿亚历山大病的神经学表现和临床结果:单中心队列和新型GFAP变异的鉴定
IF 1.3 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-11-28 DOI: 10.1016/j.braindev.2025.104488
Renu Suthar , Yashu Sharma , Arushi Gahlot Saini , Pawan Kumar , Sadhna Lal , Prateek Bhatia , Vikas Bhatia , Sameer Vyas , Priyanka Srivastava , Balamurugan Nagarajan , Savita Attri , Jitendra Sahu , Naveen Sankhyan

Background

We aimed to analyze the prevalence, clinico-radiological and genetic features, and outcomes in children with Alexander disease (AD) with special emphasis on atypical presentations.

Methods

This cross-sectional study evaluated children with AD seen over the past 10 years. Neuroimaging was evaluated by a trained neuroradiologist. In-silico tools were used to predict the pathogenicity of the novel variants detected by whole-exome sequencing.

Results

N = 12 children (males 58.3 %) with genetically-confirmed AD were evaluated. Disease subtypes were infantile (n = 7, 58.3 %), juvenile (n = 3, 25 %), and neonatal (n = 2, 16.7 %) AD. The clinic-based prevalence of AD was 0.34 cases per 1000 pediatric neurology patients per year, or an average of 1.2 cases per year. Clinical features were developmental delay (n = 9, 75 %), macrocephaly (n = 9, 75 %), spasticity (n = 6, 50 %), and epilepsy (n = 8, 66.7 %); two children with juvenile-onset disease had atypical visual and bulbar manifestations. Pathogenic variations were most common in exons 1 (n = 5, 42 %), and exon 4 (n = 4, 33.3 %). These were missense type (n = 11, 91.6 %) or deletion (n = 1, 8.3 %). Three novel variants were detected: c.251T>G (p.Ile84Ser) in exon 1, c.810_818 deletion (p.Asn271_Glu273del) in exon 5, and c.292G>C (p.Ala98Pro) in exon 1 in the GFAP gene (NM_002055). Majority of children developed spastic paresis (n = 9, 83 %) and mortality rate was 33.3 % (n = 4/12).

Conclusion

AD is a rare leukodystrophy with high mortality and progressive spastic paraparesis. Neonatal and juvenile types may present atypically and delay correct diagnosis. Deletions may account for a minor proportion of pathogenic variants. Our study expands the clinico-radiological spectrum of AD in children.
本研究旨在分析亚历山大病(AD)儿童的患病率、临床放射学和遗传学特征以及预后,并特别强调非典型表现。方法:本横断面研究评估了过去10年的AD患儿。神经影像由训练有素的神经放射学家评估。利用计算机工具预测全外显子组测序检测到的新变异的致病性。结果对遗传确诊AD患儿12例(男性58.3%)进行了评估。疾病亚型为婴儿AD (n = 7, 58.3%)、青少年AD (n = 3, 25%)和新生儿AD (n = 2, 16.7%)。阿尔茨海默病的临床患病率为每年每1000名儿科神经病学患者0.34例,或平均每年1.2例。临床表现为发育迟缓(n = 9, 75%)、大头畸形(n = 9, 75%)、痉挛(n = 6, 50%)、癫痫(n = 8, 66.7%);2例患儿有不典型的视觉和球表现。致病变异最常见于外显子1 (n = 5, 42%)和外显子4 (n = 4, 33.3%)。错义型(n = 11, 91.6%)或缺失型(n = 1, 8.3%)。在GFAP基因(NM_002055)中检测到3个新变异:第1外显子C . 251t >G (p.i ile84ser),第5外显子C .810_818缺失(p.a n271_glu273del),第1外显子C . 292g >C (p.a ala98pro)。大多数儿童发生痉挛性麻痹(n = 9, 83%),死亡率为33.3% (n = 4/12)。结论ad是一种罕见的脑白质营养不良,病死率高,伴有进行性痉挛性截瘫。新生儿和青少年型可能表现不典型,延误正确诊断。缺失可能占致病变异的一小部分。我们的研究扩展了儿童AD的临床放射谱。
{"title":"Neurological manifestations and clinical outcomes in pediatric Alexander disease: single-center cohort and identification of novel GFAP variants","authors":"Renu Suthar ,&nbsp;Yashu Sharma ,&nbsp;Arushi Gahlot Saini ,&nbsp;Pawan Kumar ,&nbsp;Sadhna Lal ,&nbsp;Prateek Bhatia ,&nbsp;Vikas Bhatia ,&nbsp;Sameer Vyas ,&nbsp;Priyanka Srivastava ,&nbsp;Balamurugan Nagarajan ,&nbsp;Savita Attri ,&nbsp;Jitendra Sahu ,&nbsp;Naveen Sankhyan","doi":"10.1016/j.braindev.2025.104488","DOIUrl":"10.1016/j.braindev.2025.104488","url":null,"abstract":"<div><h3>Background</h3><div>We aimed to analyze the prevalence, clinico-radiological and genetic features, and outcomes in children with Alexander disease (AD) with special emphasis on atypical presentations.</div></div><div><h3>Methods</h3><div>This cross-sectional study evaluated children with AD seen over the past 10 years. Neuroimaging was evaluated by a trained neuroradiologist. <em>In-silico</em> tools were used to predict the pathogenicity of the novel variants detected by whole-exome sequencing.</div></div><div><h3>Results</h3><div><em>N</em> = 12 children (males 58.3 %) with genetically-confirmed AD were evaluated. Disease subtypes were infantile (<em>n</em> = 7, 58.3 %), juvenile (<em>n</em> = 3, 25 %), and neonatal (<em>n</em> = 2, 16.7 %) AD. The clinic-based prevalence of AD was 0.34 cases per 1000 pediatric neurology patients per year, or an average of 1.2 cases per year. Clinical features were developmental delay (<em>n</em> = 9, 75 %), macrocephaly (n = 9, 75 %), spasticity (<em>n</em> = 6, 50 %), and epilepsy (<em>n</em> = 8, 66.7 %); two children with juvenile-onset disease had atypical visual and bulbar manifestations. Pathogenic variations were most common in exons 1 (<em>n</em> = 5, 42 %), and exon 4 (<em>n</em> = 4, 33.3 %). These were missense type (<em>n</em> = 11, 91.6 %) or deletion (n = 1, 8.3 %). Three novel variants were detected: c.251T&gt;G (p.Ile84Ser) in exon 1, c.810_818 deletion (p.Asn271_Glu273del) in exon 5, and c.292G&gt;C (p.Ala98Pro) in exon 1 in the <em>GFAP</em> gene (NM_002055). Majority of children developed spastic paresis (<em>n</em> = 9, 83 %) and mortality rate was 33.3 % (<em>n</em> = 4/12).</div></div><div><h3>Conclusion</h3><div>AD is a rare leukodystrophy with high mortality and progressive spastic paraparesis. Neonatal and juvenile types may present atypically and delay correct diagnosis. Deletions may account for a minor proportion of pathogenic variants. Our study expands the clinico-radiological spectrum of AD in children.</div></div>","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"47 6","pages":"Article 104488"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Brain & Development
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1